Comparative Peptide Mapping Between Two Manufacturers of Trastuzumab using The X500B QTOF System


Download your copy... 

Consistency between batches and manufacturers is of vital importance in the process of drug development and production. Efficacy and potency can be significantly impacted by inconsistency of the drug product and so precise monitoring and characterization of any differences is critical. Learn in this technical note about a simple and rapid methodology to characterize and quantify differences between biotherapeutic batches, using high-resolution peptide mapping by LC-MS.

To download your copy of this technical note complete the form opposite.

Your privacy matters. Please see SCIEX’s privacy policy to learn more about how your personal data will be treated.

Registrants for this application note are covered by the Eclipse Business Media Privacy Policy.